Impact of HIV Among Women in the United States
The Centers for Disease Control and Prevention estimates that in the United States, 1.2 million adults and adolescents are living with human immunodeficiency virus (HIV). 1 In a span of 15 years, from 1985 to 2000, the proportion of women living with HIV more than tripled. 2 The Centers for Disease Control and Prevention estimated that by the end of 2013, 232,511 women were living with HIV in the United States. 3 Today, of all of the individuals living with HIV in the United States, 25% are women, a figure that is even higher in some states. 4 There are many converging factors that make women especially vulnerable to HIV. These include but are not limited to increased disparities and needs they face because of socioeconomic and structural barriers, competing needs of taking care of family and children, an unequal role and power within a relationship, and biological differences that make them more susceptible to HIV. 5, 6 Many women combat cooccurring substance abuse and psychiatric symptoms that are largely the result of complex trauma from intimate partner violence or physical, sexual, and psychological violence by an intimate partner, 7, 8 The syndemics or confluence of these factors creates a synergy between coexisting health and social problems and factors that exacerbate and perpetuate health risks and poor health outcomes. These syndemic conditions also undermine the ability of an HIV-positive woman to adhere to her medication regimen as evidenced in the low level of viral suppression-only 23% of women with HIV in the United States are virally suppressed. 9 An application of a syndemics perspective allows us to more fully understand the complex nature of care needs faced by many women living with HIV. 1 Our study sought to answer the question: What is the feasibility and initial patient acceptability of a conjoint treatment modality to reduce client trauma symptomology and improve engagement in HIV care?
HIV and Co-Occurring Conditions: The Syndemic Nature of HIV In the United States, women living with HIV infection are disproportionately burdened by trauma such as intimate partner violence and the resultant negative health consequences, such as addiction and psychiatric symptoms, making the combination of HIV infection and trauma a syndemic illness. [10] [11] [12] Clinical management of HIVand co-occurring disorders must account for the "syndemics" or the frequently encountered "triple diagnosis" 13 of HIV, psychiatric diagnosis, and substance use disorders. Therapy for patients with complex and co-related conditions requires integrated treatment services that go beyond independent management of substance use and psychiatric and medical symptoms.
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Integrated Treatment Models
The integration of multiple perspectives to provide input into the most complex issues in science is believed to offer the best opportunity to find real-world answers to difficult problems. 15 The 2006 Institute of Medicine report Improving the Quality of Health Care for Mental and Substance-Use Conditions 16 promotes integrated clinical care approaches that can make treatment easier to access and more attractive to patients, and it can contribute to higher retention rates and better outcomes. Levels of integration vary from those with minimal collaboration, in which mental health and other healthcare providers work in separate facilities, have separate systems, and rarely communicate about cases, to those with close collaboration in a fully integrated system. Fully integrated systems are marked by communication between mental health and other healthcare professionals about the needs of individuals patients while in the same care locations, and systems. 17 Even in the most fully integrated care environments, however, real-time joint therapeutic approaches between addiction and psychiatric providers remain largely underexplored and scantly documented in the literature. This gap in evidence to support the potential efficacy of joint therapeutic approaches, often referred to as conjoint treatment, may be the result of historical divisions between medicine and addiction, educational and professional hierarchy, or by the individualized nature of treatment. For the purposes of this study, we define conjoint treatment as two providers from different disciplines meeting with the patient at the same time in a therapeutic alliance to improve patient treatment outcomes. 18 
Setting the Foundation for Conjoint Treatment: Evolution of a New Model
The conjoint treatment model (referred to as co-teaching in the field of education) has proven successful, particularly when working with students with complex individual circumstances (eg, disabilities) and family/environmental conditions. 19, 20 Drawing from the principles of co-teaching, conjoint mental health therapy promotes efficiency of the therapeutic session, in which the interdisciplinary care team can listen to one another's questions, the patient's responses, and ask additional questions only as their own assessment dictates. This approach also can reduce appointment burden for patients who struggle to manage numerous appointments with different providers.
Methods
This perspective describes pilot efforts undertaken to develop the conjoint treatment approach within a demonstration project designed to improve care services and engagement among HIVpositive women who were parenting and who used controlled and uncontrolled substances. From 2014 to 2015, a psychiatric nurse practitioner (NP) and a licensed marriage and family therapist (LMFT; together referred to henceforth as the clinician team) applied conjoint treatment in the context of an integrated treatment approach to improve patient engagement into substance use treatment among their HIV-positive female patients with mental illness and substance use burden. Participants in the conjoint sessions were women who were either pregnant or had children during the time of the study. This study was approved by the University of California, San Diego human institutional review board. We pilot tested our approach with a convenience sample of 15 patients to assess the feasibility and initial patient acceptability of the conjoint treatment modality. The NP first asked the patient's permission to invite a therapist specializing in substance use to join the session; all 15 patients who were approached agreed to participate in the conjoint session. The LMFT began meeting with the patients of the NP during their visits and rapport was built quickly across a range of 1 to 2 sessions. The clinician team observed that patients who had previously been reticent to seek substance use treatment were now willing to engage with substance use treatment in the conjoint treatment approach.
After initial success engaging 15 patients with substance use treatment during the course of 1 month, the clinician team decided to begin conjoint treatment with all new psychiatric patients who also were in need of substance use treatment. The new patients were informed that all psychiatric care included substance assessment and treatment, and that they would be seen together by the NP and LMFT if they agreed. During initial visits the NP led the psychiatric intake and the LMFT completed the Alcohol, Smoking, and Substance Involvement Screening Test, 21 which allowed for a more thorough assessment, which was beneficial for both providers to understand patients' needs. During visits the providers met with the patients together to address current symptoms, medication management, recurrence planning, and to develop coping skills. Outside of the sessions, the clinician team met to strategize approaches for the patients, plan treatment, and debrief regarding transference and countertransference issues. In time the clinicians were able to develop a rapport with one another that resembled cofacilitation of group therapy, in which each member of the clinician team applied his or her expertise when needed. For example, when a client arrived in crisis, often the NP would begin exploring psychiatric symptoms and medication issues. The LMFT then would inquire regarding substance use behavior, triggers, and challenges to recovery, as well as ask the patient how these issues could be affected by the patient's psychiatric conditions. The conjoint approach allowed for both providers to address current symptoms.
Early Engagement, Transfer of Rapport, and Retention
Rapport building between patients and clinicians can be difficult with patients who have numerous stigmatized diagnoses such as HIV, substance use disorders, and mental health disorders. Individuals who have experienced trauma, especially multiple traumas over extended periods of time, struggle to trust others and build relationships, even in neutral settings. Even when providers are able to build rapport over time with their patients, encouraging patients to adhere to referrals to other providers often can be difficult, particularly when providers are located in different settings from the referral source. By using the conjoint treatment model, we found that rapport was built rapidly between the patient and a new provider in the context of a psychiatric care visit. We observed that a therapeutic alliance with the new provider can be constructed within the context of a trusting relationship with the initial provider. Unlike the time that it takes to work toward a referral with an external provider, having the alcohol and other drugs specialist attend the session with the psychiatric provider meant that there was less need to create a readiness to engage in substance use care. This is because the conjoint treatment allowed for more timely motivational enhancement discussions at earlier stages of patient treatment engagement. Application of the conjoint treatment approach also allowed the clinical team to better manage in real time the potential disruptions that occur during the treatment of individuals with attachment issues and personality disorders. In such cases one team member can attune to the tone and interpersonal needs of the client while the other can focus on assessment and interventions.
Conjoint Treatment Is Trauma-Informed Care
Trauma-informed care is an approach to care provision by a practitioner or healthcare system that takes into consideration a patient's underlying traumatic experiences (eg, interpersonal violence) as an integral component of treatment for a condition (eg, substance abuse). 17 Trauma research and clinical practice have taught us much about the widespread problems of child maltreatment, partner violence, and sexual assault. Numerous investigations have documented links between such trauma exposure and long-term negative mental health consequences. 22 Conjoined care is trauma-informed care because it has the potential to reduce the patient's need to repeat the description of traumatic events across care providers. Crosstraining and crossdisciplinary integration of services among multiple systems (eg, mental health practitioners, frontline workers, and administrators in other childand family-serving systems) allow for a seamless provision of services and reduces the risk of reexposure to trauma through retelling their story upon entering each new system.
Professional Development/Reducing Burnout/Secondary Trauma
Conjoint treatment sessions also can prevent provider burnout and help buffer other negative effects of working with traumatized and highly affected patients. Clinician mental health can be affected by problems such as secondary traumatic stress, vicarious traumatization, and compassion fatigue, which are conceptualized as reactions to severe emotional demand. Often, mental health professionals develop secondary trauma reactions in response to their clients' emotional concerns. 23 There is compelling evidence of negative psychological effects of working with trauma victims; however, tools for effective management of secondary traumatic stress are lacking. We found that conjoint consultation was immensely beneficial to the well-being of the clinician team, offering a sense of support that was greater than could be found during treatment team meetings or clinical supervision.
Shouldering the high acuity of highly traumatized patients in a conjoint care team can lead to greater support and reduced burnout among team members. The conjoint approach allows team members to work together in the session to more effectively attend to client needs. This approach also creates a dynamic of professional development, in which team members from different disciplines can learn from one another in the moment. This can happen across multiple domains, such as during assessment and intervention, and can lead to improved attunement to the patient's emotional state.
Conclusions
Given the high acuity of women affected by syndemic conditions of HIV including substance use disorders and trauma/ mental illness, it is imperative that new paradigms of treatment be conceptualized, evaluated, and used. We propose the conjoint treatment model as one such treatment paradigm. Shown to have efficacy in other fields (eg, education), the conjoint treatment model may be particularly useful to improve health outcomes and well-being among highly traumatized women living with HIV. In our experience with these and other women, we have observed that the conjoint treatment model has shown initial efficacy to increase patient likelihood of making and keeping appointments (ie, improved care engagement) and reducing splitting, a maladaptive defense mechanism whereby individuals view circumstances as "all good" or "all bad" to ward off unbearable feelings and emotions. The syndemic nature of these conditions requires a more comprehensive treatment approach that is capable of addressing the complexity of multiple diseases. In other words, just as illnesses are not separate, seeing providers separately may not provide the therapeutic effect for patients with complex conditions. We propose that this treatment may benefit most those patients with highly complex medical needs (including trauma) who see multiple providers.
Future research is needed to develop an intervention protocol and further assess the feasibility and acceptability of this treatment modality among women living with HIV. A subsequent pilot test and an additional rigorous evaluation and cost-benefit study could follow to determine changes in health outcomes and public health cost savings. Our experience indicates that, in the absence of more effective methods of improving the health and well-being of highly vulnerable women, conjoint treatment is worthy of additional study.
